Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Towards optimization of cardiovascular stability in neonates with hypertrophic cardiomyopathy: uniqueness of the neonatal cardiovascular system

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Patient level data.

References

  1. Loomba R, Flores S, Bronicki RA. Vasopressin in neonatal hypertrophic cardiomyopathy: cosmetic or helpful? J Perinatol. 2020.

  2. Deorari AK, Saxena A, Singh M, Shrivastava S. Echocardiographic assessment of infants born to diabetic mothers. Arch Dis Child. 1989;64:721–4.

    Article  CAS  Google Scholar 

  3. Barbara DW, Hyder JA, Behrend TL, Abel MD, Schaff HV, Mauermann WJ. Safety of noncardiac surgery in patients with hypertrophic obstructive cardiomyopathy at a tertiary care center. J Cardiothorac Vasc Anesth. 2016;30:659–64.

    Article  Google Scholar 

  4. Way GL, Wolfe RR, Eshaghpour E, Bender RL, Jaffe RB, Ruttenberg HD. The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr. 1979;95:1020–5.

    Article  CAS  Google Scholar 

  5. Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circulation. 1978;57:549–56.

    Article  CAS  Google Scholar 

  6. Verma AK, Sun JL, Hernandez A, Teerlink JR, Schulte PJ, Ezekowitz J, et al. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF. Clin Cardiol. 2018;41:945–52.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. J. McNamara.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giesinger, R.E., Boyd, S.M., Rios, D.R. et al. Towards optimization of cardiovascular stability in neonates with hypertrophic cardiomyopathy: uniqueness of the neonatal cardiovascular system. J Perinatol 41, 907–908 (2021). https://doi.org/10.1038/s41372-021-00926-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-021-00926-w

This article is cited by

Search

Quick links